Diamyd Medical AB (publ) (STO: DMYD.B)
Sweden
· Delayed Price · Currency is SEK 14.48
-0.04 (-0.28%)
Oct 4, 2024, 5:29 PM CET
Diamyd Medical AB Revenue
Diamyd Medical AB had revenue of 52.00K SEK in the quarter ending May 31, 2024, a decrease of -64.86%. This brings the company's revenue in the last twelve months to 185.00K, down -68.54% year-over-year. In the fiscal year ending August 31, 2023, Diamyd Medical AB had annual revenue of 546.00K with 20.26% growth.
Revenue (ttm)
185.00K
Revenue Growth
-68.54%
P/S Ratio
n/a
Revenue / Employee
7.40K
Employees
25
Market Cap
1.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2023 | 546.00K | 92.00K | 20.26% |
| Aug 31, 2022 | 454.00K | 201.00K | 79.45% |
| Aug 31, 2021 | 253.00K | -88.00K | -25.81% |
| Aug 31, 2020 | 341.00K | -1.23M | -78.25% |
| Aug 31, 2019 | 1.57M | 842.00K | 115.98% |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
| Aug 31, 2015 | Pro | Pro | Pro |
| Aug 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 520.76B |
| Swedish Orphan Biovitrum AB (publ) | 23.71B |
| Getinge AB (publ) | 33.33B |
| Sectra AB (publ) | 3.17B |
| Camurus AB (publ) | 1.59B |
| Vitrolife AB (publ) | 3.54B |
| Medicover AB (publ) | 21.70B |
| Elekta AB (publ) | 18.12B |